Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
Clinical trial NCT01416038 · COMPLETED
Trial details
- NCT number
- NCT01416038
- Sponsor
- ImmunoVaccine Technologies, Inc. (IMV Inc.)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-05-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.